Blunt Chest TraumaNCT07432048
Non-Invasive Dynamic Monitoring-Guided Oscillation and Lung Expansion for Airway Clearance in Severe Blunt Chest Trauma: A Clinical Study
An observational study of Blunt Chest Trauma, run by Peking University People's Hospital.
Trial summary
In our previous study, the investigators analyzed more than 30,000 cases from the National Trauma Center Database and found that 66.4% of patients with severe blunt chest trauma had concurrent rib fractures, 55.87% had multiple fractures (≥4 ribs), and 37.4% had combined pulmonary contusion. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Blunt Chest Trauma
- What is being tested?
- Different therapeutic interventions
- How many people
- 80 participants
- Where
- No sites listed yet
- Study dates
- Mar 2026to Nov 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: the cohort will be selected from a tertiary hospital
Who may be able to join
- Severe blunt chest trauma, defined as injury caused by blunt force such as chest impact or compression, with an Abbreviated Injury Scale (AIS) score of the chest ≥ 3
- Age 18 to 70 years
- Time from injury to enrollment < 48 hours
- Receiving invasive mechanical ventilation, with duration of mechanical ventilation < 24 hours
- Written informed consent signed by the patient or his/her legal representative
Who cannot join
- Combined penetrating chest trauma
- Perinatal women
- Inability of the patient to cooperate with examinations and treatment
- Contraindications to EIT monitoring, including implanted cardiac pacemaker, unhealed local skin wound after thoracic surgery, extensive subcutaneous emphysema of the chest, etc
- Contraindications to OLE therapy:
- Hemodynamic instability (heart rate < 60 beats/min or > 130 beats/min; systolic blood pressure < 90 mmHg or > 180 mmHg; or mean arterial pressure < 60 mmHg or > 100 mmHg)
Show all 14Show fewer
- Unstable angina pectoris or cardiac arrhythmia
- Intracranial pressure > 20 mmHg
- Active bleeding
- Suspected or active hemoptysis
- Undrained pneumothorax
- Unstable deep vein thrombosis or pulmonary embolism
- Unstable spinal or long bone fractures
- Unstable head and neck injury
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
In our previous study, the investigators analyzed more than 30,000 cases from the National Trauma Center Database and found that 66.4% of patients with severe blunt chest trauma had concurrent rib fractures, 55.87% had multiple fractures (≥4 ribs), and 37.4% had combined pulmonary contusion. In a further prospective observational cohort study evaluating the efficacy of EIT-guided OLE in such patients, results demonstrated that this protocol improved the ventilation-perfusion ratio and oxygenation index and shortened total mechanical ventilation duration. Based on literature review and preliminary findings, the investigators propose the following hypothesis: the application of EIT-noninvasively monitored OLE airway clearance in patients with severe blunt chest trauma can improve the ventilation-perfusion ratio, shorten mechanical ventilation time, reduce the incidence of complications such as pulmonary infection and mortality, and decrease medical resource consumption.
This study will verify this hypothesis through a prospective randomized controlled trial and further refine the specific implementation protocol of OLE to enhance its scientific validity and clinical applicability.
Read the detailed description
Trauma is one of the top ten causes of death across all age groups, and among young adults under 45 years of age, trauma has remained the leading cause of death for nearly four decades. As a megacity, Beijing features complex traffic conditions and a dense population, resulting in a high incidence of multiple injuries such as traffic injuries and falls from height. Such trauma is often accompanied by multiple organ injuries, which not only makes treatment difficult and costly but also significantly increases the financial burden on families and causes losses in social productivity due to long-term rehabilitation requirements and loss of working capacity. Improving treatment protocols and promoting advanced technologies can improve patient survival and reduce the need for long-term care. Establishing an efficient prevention and treatment system helps reduce redundant consumption of medical resources, alleviate pressure on medical insurance funds, and thereby release more resources to support economic and livelihood development. Therefore, reducing trauma mortality in young and middle-aged adults plays a critical role in stabilizing the labor supply, promoting urban modernization, and implementing the Healthy China strategy.
More than one-quarter of trauma patients eventually die from chest trauma and its related complications . The risk of pulmonary infection in trauma patients is four times higher than that in non-trauma patients. Rib fractures, pulmonary contusion, hemothorax, and procedures such as closed thoracic drainage and endotracheal intubation are all important risk factors for pulmonary infection. In patients with severe blunt chest trauma, the proportion of fractures involving stable thoracic structures such as ribs and sternum can reach 36.1%. Such fractures not only cause severe pain but, more importantly, approximately 10% of patients may develop flail chest with paradoxical respiratory motion, which severely disrupts normal respiratory mechanics and impairs the patient's ability to clear the airway through active coughing.
The incidence of pulmonary contusion exceeds 70% in severely injured patients and accounts for more than 50% of all chest traumas, particularly in high-speed motor vehicle-related trauma-the predominant injury mechanism of trauma in China. Pulmonary contusion not only directly injures the lung parenchyma but, more crucially, significantly increases the risk of atelectasis when coexisting with flail chest. Atelectasis leads to local alveolar collapse, impaired gas exchange, and further deterioration of airway self-clearing capacity. Restrictive ventilatory disorders caused by atelectasis and flail chest, together with hemorrhage and exudation from pulmonary contusion, create a highly favorable environment for pulmonary infection. Studies have reported that the incidence of pulmonary infection in such patients can exceed 21%. Infection not only directly exacerbates respiratory failure but is also a key trigger for sepsis, acute respiratory distress syndrome (ARDS), and even multiple organ failure. These severe complications progress sequentially to form a fatal pathological cascade, markedly increasing the risk of death.
Therefore, in-depth research and establishment of an airway clearance protocol for patients with severe blunt chest trauma are critically important. Its core objective is to interrupt the fatal chain from rib fracture, pulmonary contusion, and atelectasis to severe infection and organ failure. By improving respiratory failure, ensuring systemic oxygen supply, supporting patients through the acute phase, and effectively preventing or treating complications such as pulmonary infection, the prognosis can be significantly improved, mortality reduced, and excessive consumption of medical resources decreased.Blunt chest trauma is mainly caused by high-speed motor vehicle crashes, occupational injuries, and falls from height. Injury often immediately damages bony structures including the ribs, sternum, scapula, and spine. The incidence of rib fractures among trauma admissions is as high as 10%. The vast majority of patients with rib fractures are prone to varying degrees of atelectasis due to pain and restricted thoracic movement. More than 30% develop secondary complications such as pulmonary infection, which becomes an important cause of death. Rib fractures not only induce severe pain-especially during deep breathing and coughing-but also severely impair chest wall mechanical stability, restrict respiratory excursion, reduce tidal volume, and weaken effective cough capacity. This mechanical dysfunction combined with pain suppresses ventilation, impairs airway clearance, leads to sputum retention, and significantly increases the risk of pulmonary infection and respiratory failure.
Currently, rib fractures are mainly managed conservatively. Multimodal analgesia (e.g., opioids or regional blocks) is commonly used in elderly patients; although pain is relieved, respiratory drive and cough reflex may be further suppressed. Surgical fixation may be considered in patients with flail chest or those under 65 years of age to enhance chest wall stability and reduce mortality. However, continuous airway clearance therapy is still required postoperatively; otherwise, complications such as ventilator-associated pneumonia, unplanned intubation, and prolonged ICU stay may still occur.
Pulmonary contusion refers to a pathological state in which chest trauma causes direct or indirect injury to the lung parenchyma, leading to edema or alveolar hemorrhage, resulting in structural and functional lung damage. Injury mechanisms include chest compression, inertial effects, and implosion effects, which can cause detachment of alveoli and pulmonary interstitium, laceration of small vessels, and destruction of cellular structures. Increased intra-alveolar hemorrhage and exudation, bronchiolar spasm, and extensive injury can also lead to lung consolidation and necrosis. Furthermore, injury can trigger inflammatory imbalance and immune dysfunction, resulting in systemic inflammatory response syndrome, apoptosis and necrosis of immune cells, and pulmonary edema due to increased pulmonary capillary permeability, which may progress to ARDS 24-48 hours after injury. Patients subsequently enter a post-traumatic immunosuppressive state with recurrent infections and complicated clinical courses.
Necrotic tissue, exudate, and blood accumulate within alveoli, forming an ideal environment for infection. Multiple studies have confirmed that pulmonary contusion is an independent risk factor for pulmonary infection in trauma patients. Therefore, the development of efficient, low-risk airway clearance techniques that do not compromise respiratory function has become critical to improving the prognosis of such patients.
Mechanical airway clearance techniques refer to therapeutic methods that remove airway secretions and maintain airway patency via mechanical means. Studies have shown that these techniques effectively eliminate secretions, regulate airflow to relieve dyspnea, prevent and reduce respiratory infections, and promote recovery of respiratory function, with significant benefits in delaying disease progression, alleviating symptoms, and enhancing exercise capacity and quality of life. However, their efficacy varies considerably among individuals, influenced by age, disease severity, airway pathophysiology, device usability, and comfort. Currently, literature on the application of such techniques in patients with severe blunt chest trauma remains relatively scarce.
Mechanical airway clearance techniques include airway expansion and lung recruitment, intrapulmonary/chest wall oscillation, and other adjuvant methods. Following blunt chest trauma, tracheal collapse often occurs, and mucus hypersecretion leads to obstruction of small airways and alveoli by mucus plugs, causing localized emphysema or atelectasis. Retained mucus plugs further aggravate airway obstruction. Lung expansion techniques increase intraluminal pressure to promote airway dilation, elevate alveolar pressure and ventilation volume, help reopen occluded small airways, recruit alveoli, and facilitate secretion drainage. Oscillation techniques are classified into intrapulmonary oscillation and chest wall oscillation. Intrapulmonary oscillation delivers high-frequency oscillatory waves into the central airways, propagating to small and medium airways, which loosens and liquefies mucus and metabolic debris. Shear forces generated by airflow changes help separate secretions from the airway wall while enhancing ciliary movement to promote expectoration. In contrast, chest wall oscillation is clearly unsuitable for chest trauma patients, especially those with concurrent rib fractures.
In our previous study, the investigators analyzed more than 30,000 cases from the National Trauma Center Database and found that 66.4% of patients with severe blunt chest trauma had concurrent rib fractures, 55.87% had multiple fractures (≥4 ribs), and 37.4% had combined pulmonary contusion. In a further prospective observational cohort study evaluating the efficacy of EIT-guided OLE in such patients, results demonstrated that this protocol improved the ventilation-perfusion ratio and oxygenation index and shortened total mechanical ventilation duration. Based on literature review and preliminary findings, the investigators propose the following hypothesis: the application of EIT-noninvasively monitored OLE airway clearance in patients with severe blunt chest trauma can improve the ventilation-perfusion ratio, shorten mechanical ventilation time, reduce the incidence of complications such as pulmonary infection and mortality, and decrease medical resource consumption.
- Conditions
- Blunt Chest Trauma
- Being tested
- Different therapeutic interventions
- Keywords
- blunt chest trauma, pulmonary contusion, oscillation and lung expansion, electrical Impedance Tomography
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Different therapeutic interventionsOther
Eligible patients who met the inclusion and exclusion criteria were randomly assigned to the intervention group and the control group at a 1:1 ratio.
Intervention group: received OLE airway clearance therapy guided by noninvasive monitoring technology.
Control group: received conventional airway clearance therapy, including routine suction via flexible bronchoscopy, etc.
| Study group | Role | What they receive |
|---|---|---|
| The intervention group received an OLE airway clearance therapy regimen guided by noninvasive monito | Not described Receives: Other: Different therapeutic interventions | |
| The control group received a conventional airway clearance therapy regimen. | Not described Receives: Other: Different therapeutic interventions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cumulative total duration of the first mechanical ventilation (hours)
Measured: through study completion, an average of 1 year
Secondary outcomes (8)
Degree of improvement in ventilation/perfusion (V/Q) matching
Measured: through study completion, an average of 1 year
Incidence of ventilator-associated pneumonia (VAP) during ICU stay
Measured: through study completion, an average of 1 year
Length of ICU stay
Measured: through study completion, an average of 1 year
Length of total hospital stay
Measured: through study completion, an average of 1 year
28-day all-cause mortality
Measured: through study completion, an average of 1 year
90-day all-cause mortality
Measured: through study completion, an average of 1 year
First successful weaning rate
Measured: through study completion, an average of 1 year
total cost in icu
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Feb 2026
- Study startMar 2026 (estimated)
- Primary completionSep 2027 (estimated)
- Study completionNov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blunt Chest TraumaStudies of the same condition, open and under way.
- More trials run by Peking University People's HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 80 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Peking University People's Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Li Shu, Peking University People's Hospital
- Investigators
- Shu Li, doctor, Principal investigator, Peking University People's Hosptial
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07432048
- Sponsor's protocol ID
- RDL2025-21
- Status last verified
- Feb 2026
- First submitted
- 8 Feb 2026
- Last updated
- 25 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: all collected IPD that underlie results in a publication
Study at a glance
From the registry record, last updated by the sponsor on 25 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Non-Invasive Dynamic Monitoring-Guided Oscillation and Lung Expansion for Airway Clearance in Severe Blunt Chest Trauma: A Clinical Study
- ClinicalTrials.gov ID
- NCT07432048
- Acronym / sponsor ID
- RDL2025-21
- Conditions
- Blunt Chest Trauma
- Keywords
- blunt chest trauma, pulmonary contusion, oscillation and lung expansion, electrical Impedance Tomography
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 80 participants (estimated)
- Lead sponsor
- Peking University People's HospitalUniversity, hospital or other
- Study start
- Mar 2026 (estimated)
- Primary completion
- Sep 2027 (estimated)
- Study completion
- Nov 2027 (estimated)
- First posted
- 25 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In our previous study, the investigators analyzed more than 30,000 cases from the National Trauma Center Database and found that 66.4% of patients with severe blunt chest trauma had concurrent rib fractures, 55.87% had multiple fractures (≥4 ribs), and 37.4% had combined pulmonary contusion. In a further prospective observational cohort study evaluating the efficacy of EIT-guided OLE in such patients, results demonstrated that this protocol improved the ventilation-perfusion ratio and oxygenation index and shortened total mechanical ventilation duration. Based on literature review and preliminary findings, the investigators propose the following hypothesis: the application of EIT-noninvasively monitored OLE airway clearance in patients with severe blunt chest trauma can improve the ventilation-perfusion ratio, shorten mechanical ventilation time, reduce the incidence of complications such as pulmonary infection and mortality, and decrease medical resource consumption.
This study will verify this hypothesis through a prospective randomized controlled trial and further refine the specific implementation protocol of OLE to enhance its scientific validity and clinical applicability.
Detailed description
Trauma is one of the top ten causes of death across all age groups, and among young adults under 45 years of age, trauma has remained the leading cause of death for nearly four decades. As a megacity, Beijing features complex traffic conditions and a dense population, resulting in a high incidence of multiple injuries such as traffic injuries and falls from height. Such trauma is often accompanied by multiple organ injuries, which not only makes treatment difficult and costly but also significantly increases the financial burden on families and causes losses in social productivity due to long-term rehabilitation requirements and loss of working capacity. Improving treatment protocols and promoting advanced technologies can improve patient survival and reduce the need for long-term care. Establishing an efficient prevention and treatment system helps reduce redundant consumption of medical resources, alleviate pressure on medical insurance funds, and thereby release more resources to support economic and livelihood development. Therefore, reducing trauma mortality in young and middle-aged adults plays a critical role in stabilizing the labor supply, promoting urban modernization, and implementing the Healthy China strategy.
More than one-quarter of trauma patients eventually die from chest trauma and its related complications . The risk of pulmonary infection in trauma patients is four times higher than that in non-trauma patients. Rib fractures, pulmonary contusion, hemothorax, and procedures such as closed thoracic drainage and endotracheal intubation are all important risk factors for pulmonary infection. In patients with severe blunt chest trauma, the proportion of fractures involving stable thoracic structures such as ribs and sternum can reach 36.1%. Such fractures not only cause severe pain but, more importantly, approximately 10% of patients may develop flail chest with paradoxical respiratory motion, which severely disrupts normal respiratory mechanics and impairs the patient's ability to clear the airway through active coughing.
The incidence of pulmonary contusion exceeds 70% in severely injured patients and accounts for more than 50% of all chest traumas, particularly in high-speed motor vehicle-related trauma-the predominant injury mechanism of trauma in China. Pulmonary contusion not only directly injures the lung parenchyma but, more crucially, significantly increases the risk of atelectasis when coexisting with flail chest. Atelectasis leads to local alveolar collapse, impaired gas exchange, and further deterioration of airway self-clearing capacity. Restrictive ventilatory disorders caused by atelectasis and flail chest, together with hemorrhage and exudation from pulmonary contusion, create a highly favorable environment for pulmonary infection. Studies have reported that the incidence of pulmonary infection in such patients can exceed 21%. Infection not only directly exacerbates respiratory failure but is also a key trigger for sepsis, acute respiratory distress syndrome (ARDS), and even multiple organ failure. These severe complications progress sequentially to form a fatal pathological cascade, markedly increasing the risk of death.
Therefore, in-depth research and establishment of an airway clearance protocol for patients with severe blunt chest trauma are critically important. Its core objective is to interrupt the fatal chain from rib fracture, pulmonary contusion, and atelectasis to severe infection and organ failure. By improving respiratory failure, ensuring systemic oxygen supply, supporting patients through the acute phase, and effectively preventing or treating complications such as pulmonary infection, the prognosis can be significantly improved, mortality reduced, and excessive consumption of medical resources decreased.Blunt chest trauma is mainly caused by high-speed motor vehicle crashes, occupational injuries, and falls from height. Injury often immediately damages bony structures including the ribs, sternum, scapula, and spine. The incidence of rib fractures among trauma admissions is as high as 10%. The vast majority of patients with rib fractures are prone to varying degrees of atelectasis due to pain and restricted thoracic movement. More than 30% develop secondary complications such as pulmonary infection, which becomes an important cause of death. Rib fractures not only induce severe pain-especially during deep breathing and coughing-but also severely impair chest wall mechanical stability, restrict respiratory excursion, reduce tidal volume, and weaken effective cough capacity. This mechanical dysfunction combined with pain suppresses ventilation, impairs airway clearance, leads to sputum retention, and significantly increases the risk of pulmonary infection and respiratory failure.
Currently, rib fractures are mainly managed conservatively. Multimodal analgesia (e.g., opioids or regional blocks) is commonly used in elderly patients; although pain is relieved, respiratory drive and cough reflex may be further suppressed. Surgical fixation may be considered in patients with flail chest or those under 65 years of age to enhance chest wall stability and reduce mortality. However, continuous airway clearance therapy is still required postoperatively; otherwise, complications such as ventilator-associated pneumonia, unplanned intubation, and prolonged ICU stay may still occur.
Pulmonary contusion refers to a pathological state in which chest trauma causes direct or indirect injury to the lung parenchyma, leading to edema or alveolar hemorrhage, resulting in structural and functional lung damage. Injury mechanisms include chest compression, inertial effects, and implosion effects, which can cause detachment of alveoli and pulmonary interstitium, laceration of small vessels, and destruction of cellular structures. Increased intra-alveolar hemorrhage and exudation, bronchiolar spasm, and extensive injury can also lead to lung consolidation and necrosis. Furthermore, injury can trigger inflammatory imbalance and immune dysfunction, resulting in systemic inflammatory response syndrome, apoptosis and necrosis of immune cells, and pulmonary edema due to increased pulmonary capillary permeability, which may progress to ARDS 24-48 hours after injury. Patients subsequently enter a post-traumatic immunosuppressive state with recurrent infections and complicated clinical courses.
Necrotic tissue, exudate, and blood accumulate within alveoli, forming an ideal environment for infection. Multiple studies have confirmed that pulmonary contusion is an independent risk factor for pulmonary infection in trauma patients. Therefore, the development of efficient, low-risk airway clearance techniques that do not compromise respiratory function has become critical to improving the prognosis of such patients.
Mechanical airway clearance techniques refer to therapeutic methods that remove airway secretions and maintain airway patency via mechanical means. Studies have shown that these techniques effectively eliminate secretions, regulate airflow to relieve dyspnea, prevent and reduce respiratory infections, and promote recovery of respiratory function, with significant benefits in delaying disease progression, alleviating symptoms, and enhancing exercise capacity and quality of life. However, their efficacy varies considerably among individuals, influenced by age, disease severity, airway pathophysiology, device usability, and comfort. Currently, literature on the application of such techniques in patients with severe blunt chest trauma remains relatively scarce.
Mechanical airway clearance techniques include airway expansion and lung recruitment, intrapulmonary/chest wall oscillation, and other adjuvant methods. Following blunt chest trauma, tracheal collapse often occurs, and mucus hypersecretion leads to obstruction of small airways and alveoli by mucus plugs, causing localized emphysema or atelectasis. Retained mucus plugs further aggravate airway obstruction. Lung expansion techniques increase intraluminal pressure to promote airway dilation, elevate alveolar pressure and ventilation volume, help reopen occluded small airways, recruit alveoli, and facilitate secretion drainage. Oscillation techniques are classified into intrapulmonary oscillation and chest wall oscillation. Intrapulmonary oscillation delivers high-frequency oscillatory waves into the central airways, propagating to small and medium airways, which loosens and liquefies mucus and metabolic debris. Shear forces generated by airflow changes help separate secretions from the airway wall while enhancing ciliary movement to promote expectoration. In contrast, chest wall oscillation is clearly unsuitable for chest trauma patients, especially those with concurrent rib fractures.
In our previous study, the investigators analyzed more than 30,000 cases from the National Trauma Center Database and found that 66.4% of patients with severe blunt chest trauma had concurrent rib fractures, 55.87% had multiple fractures (≥4 ribs), and 37.4% had combined pulmonary contusion. In a further prospective observational cohort study evaluating the efficacy of EIT-guided OLE in such patients, results demonstrated that this protocol improved the ventilation-perfusion ratio and oxygenation index and shortened total mechanical ventilation duration. Based on literature review and preliminary findings, the investigators propose the following hypothesis: the application of EIT-noninvasively monitored OLE airway clearance in patients with severe blunt chest trauma can improve the ventilation-perfusion ratio, shorten mechanical ventilation time, reduce the incidence of complications such as pulmonary infection and mortality, and decrease medical resource consumption.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| The intervention group received an OLE airway clearance therapy regimen guided by noninvasive monito | – | Other: Different therapeutic interventions |
| The control group received a conventional airway clearance therapy regimen. | – | Other: Different therapeutic interventions |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- the cohort will be selected from a tertiary hospital
Key inclusion criteria (5 listed)
- Severe blunt chest trauma, defined as injury caused by blunt force such as chest impact or compression, with an Abbreviated Injury Scale (AIS) score of the chest ≥ 3
- Age 18 to 70 years
- Time from injury to enrollment < 48 hours
- Receiving invasive mechanical ventilation, with duration of mechanical ventilation < 24 hours
- Written informed consent signed by the patient or his/her legal representative
Key exclusion criteria (14 listed)
- Combined penetrating chest trauma
- Perinatal women
- Inability of the patient to cooperate with examinations and treatment
- Contraindications to EIT monitoring, including implanted cardiac pacemaker, unhealed local skin wound after thoracic surgery, extensive subcutaneous emphysema of the chest, etc
- Contraindications to OLE therapy:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Different therapeutic interventionsEligible patients who met the inclusion and exclusion criteria were randomly assigned to the intervention group and the control group at a 1:1 ratio. Intervention group: received OLE airway clearance therapy guided by noninvasive monitoring technology. Control group: received conventional airway clearance therapy, including routine suction via flexible bronchoscopy, etc. | Other | The control group received a conventional airway clearance therapy regimen., The intervention group received an OLE airway clearance therapy regimen guided by noninvasive monito |
Primary outcome
Cumulative total duration of the first mechanical ventilation (hours)
Time frame: through study completion, an average of 1 year
8 secondary outcomes
Degree of improvement in ventilation/perfusion (V/Q) matching
Time frame: through study completion, an average of 1 year
Incidence of ventilator-associated pneumonia (VAP) during ICU stay
Time frame: through study completion, an average of 1 year
Length of ICU stay
Time frame: through study completion, an average of 1 year
Length of total hospital stay
Time frame: through study completion, an average of 1 year
28-day all-cause mortality
Time frame: through study completion, an average of 1 year
90-day all-cause mortality
Time frame: through study completion, an average of 1 year
First successful weaning rate
Time frame: through study completion, an average of 1 year
total cost in icu
Time frame: through study completion, an average of 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Feb 2026.
- Individual participant dataSharing planned: Yes. all collected IPD that underlie results in a publication
Related trials for Blunt Chest Trauma
Not yet recruitingObservational study
Medical,Nursing Record,PE, Blood Test and Radiological Examination ,Morality and Mobility of Multiple Trauma Patient
Trauma Centers/Statistics & Numerical Data, Trauma Blunt
Active, not recruiting
Effectiveness of an Innovative Chest Stabilizer in Rib Fracture Treatment: Impact on Respiratory Function, Complications, and Clinical Outcomes
Rib Fractures, Blunt Chest Trauma
RecruitingObservational study
GNRI and PNI for Predicting Short-Term Outcomes in Older Adults With Multiple Rib Fractures
Multiple Rib Fractures, Isolated Blunt Thoracic Trauma
Not yet recruitingObservational study
Combined Lung and Diaphragmatic Ultrasound to Predict Respiratory Failure in Blunt Chest Trauma
Blunt Chest Trauma, Respiratory Failure
Active, not recruitingObservational study
Blunt Traumatic Aortic Injury
Blunt Traumatic Aortic Injury, BTAI
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Shu Li, doctor principal investigator
Peking University People's Hosptial
Questions about this trial
What is this clinical trial studying?
An observational study of Blunt Chest Trauma, run by Peking University People's Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 25 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Shu Li, doctor (+86 010 8832 4480, lishu2401@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cumulative total duration of the first mechanical ventilation (hours) (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2026.